- Part 21: For the preceding part double click ID:nRSH4027Rt
Illegal trade in our productsThe illegal trade in pharmaceutical products Impact Public loss of confidence in the integrity of pharmaceutical products as a result of illegal trade could materially adversely affect our reputation and financial performance. In addition, undue or misplaced concern about this issue may cause some patients to stop taking their medicines, with consequential risks to their health. Authorities may take action, financial or otherwise, if they believe we are liable for breaches in our own supply chains.There is also a direct financial loss when counterfeit and/or illegally diverted products replace sales of genuine products; or genuine products are recalled following discovery of counterfeit products; or products which have been the subject of theft or illegal diversion are recalled; or illegally diverted products replace sales of products which are approved/allowed for sale in a market.
is widely recognised by industry, non-governmental organisations and
governmental authorities to be increasing. Illegal trade includes
counterfeiting, theft and illegal diversion (that is, when our products
are found in a market where we did not send them and where they are not
approved or not permitted/allowed to be sold). There is a risk to public
health when illegally traded products enter the supply chain, as well as
associated financial risk. Authorities and the public expect us to help
reduce opportunities for illegal trade in our products through securing
the integrity of our supply chain, surveillance, investigation and
supporting legal action against those found to be engaged in illegal
- More to follow, for following part double click ID:nRSH4027Rv